Results 291 to 300 of about 24,734 (337)

Correction: Zeng et al. Myricetin Potentiates Antibiotics Against Resistant <i>Pseudomonas aeruginosa</i> by Disrupting Biofilm Formation and Inhibiting Motility Through FimX-Mediated c-di-GMP Signaling Interference. <i>Biology</i> 2025, <i>14</i>, 859. [PDF]

Biology (Basel)
Zeng D, Jiao F, Yang Y, Dou S, Yu J, Yu X, Zhou Y, Xue J, Li X, Duan H, Zhang Y, Guo J, Yang W.   +12 more
europepmc   +1 more source

Trajectories of medication for opioid use disorder and their impact on HIV testing among people who inject drugs in India: A longitudinal assessment of clinic‐based data

Addiction, Volume 120, Issue 4, Page 745-755, April 2025.
Abstract Aims The aim of this study was to identify longitudinal trajectories of medication for opioid use disorder (MOUD) use throughout 1 year following MOUD initiation and to examine the association of trajectory membership with HIV testing among people who inject drugs in India.
Allison M. McFall, Lakshmi Ganapathi, Mihili P. Gunaratne, Aylur K. Srikrishnan, Conjeevaram K. Vasudevan, Santhanam Anand, Sunil S. Solomon, Shruti H. Mehta, Gregory M. Lucas   +8 more
wiley   +1 more source

Structures of the multi-domain oxygen sensor DosP: remote control of a c-di-GMP phosphodiesterase by a regulatory PAS domain. [PDF]

Nat Commun
Wu W, Kumar P, Brautigam CA, Tso SC, Baniasadi HR, Kober DL, Gilles-Gonzalez MA.   +6 more
europepmc   +1 more source

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction, EarlyView.
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock, Krista J. Siefried, Gill Bedi, Steven Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett   +8 more
wiley   +1 more source

Stenotrophomonas maltophilia uses a c-di-GMP module to sense the mammalian body temperature during infection. [PDF]

PLoS Pathog
Wang Y, Wang KM, Zhang X, Wang W, Qian W, Wang FF.   +5 more
europepmc   +1 more source

Comparative Genomic and Functional Analysis of c-di-GMP Metabolism and Regulatory Proteins in Bacillus velezensis LQ-3. [PDF]

Microorganisms
Li R, Yang P, Zhang H, Wang C, Zhao F, Liu J, Wang Y, Liang Y, Sun T, Xie X.   +9 more
europepmc   +1 more source

The structural basis for high-affinity c-di-GMP binding to the GSPII-B domain of the traffic ATPase PilF from Thermus thermophilus. [PDF]

J Biol Chem
Neißner K, Keller H, Kirchner L, Düsterhus S, Duchardt-Ferner E, Averhoff B, Wöhnert J.   +6 more
europepmc   +1 more source

A Label-Free Approach for Relative Spatial Quantitation of c-di-GMP in Microbial Biofilms. [PDF]

Anal Chem
McCaughey CS, Trebino MA, McAtamney A, Isenberg RY, Mandel MJ, Yildiz FH, Sanchez LM.   +6 more
europepmc   +1 more source

A c-di-GMP binding effector STM0435 modulates flagellar motility and pathogenicity in Salmonella. [PDF]

Virulence
Dai Y, Liu R, Yue Y, Song N, Jia H, Ma Z, Gao X, Zhang M, Yuan X, Liu Q, Liu X, Li B, Wang W.   +12 more
europepmc   +1 more source

Human KIT Antibody Briquilimab Diminishes Anaphylactic Responses in Mice Expressing Chimeric Human‐Mouse KIT

Allergy, EarlyView.
Hye‐Sook Kwon, Song Eun Lee, Ajay Sharma, Minyoung Youn, Charles A. Chang, Andrew Wells, Andrea R. Romo, Allison Ji, Sara Ratia, Sambidhan Kattel, Revati Nerkar, Karl Meneses, Cheryl Kwan, Mang Yu, Wendy W. Pang   +14 more
wiley   +1 more source